Medicaid and Government Pricing Congress
Critical Policy Updates and Approaches for Companies to Effectively Contract, Report and Comply with State and Federal Healthcare Programs
Medicare Pricing & Contracting Congress
In-Depth Analysis on the Latest Policy and Reform Initiatives Impacting Pricing, Quality and Transparency
6th Edition Drug Pricing Transparency Congress
Stay on the Pulse of Federal and State Reporting Requirements, Policy Initiatives and Strategic Best Practices for Compliance
5th Annual IDN and Bio/Pharma Partnering Summit
Collaboration Playbook for Advancing Access and Improving Outcomes Across the Care Continuum
Articles & Video
Can payment models for gene therapies evolve fast enough to keep up?
Gene therapy is revolutionizing healthcare, but can we revolutionize payment models in time to keep up?
HCEI and PIE: Is it time for pharma to be proactive in the argument over cost effectiveness?
How can drug manufacturers embracing the FDA's new HCEI and PIE guidance to engage payer customers early? Jeremy Schafer, PharmD, MBA, SVP, Precision for Value explores.
Speed to IND: Balancing risk and reward
This eBook records an interview with Susan Dana Jones (Harpoon Therapeutics) about balancing speed to IND without leaving gaps in process understanding and scalability.
Let us help you engage qualified decision makers in need of experts and services to navigate global life science regulation. Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.
To find out more about sponsor opportunities, contact Derek Tagliarino:
firstname.lastname@example.org | +1-339-298-2206
All opportunities can be customised to align with your needs and budget. Examples may include:
- Exhibition space
- Speaking slots and onsite video interviews
- High-impact branding and messaging
- Private/public hosted events (lunches, breakfasts, and receptions)
- Custom digital campaigns